Structural Basis for Executioner Caspase Recognition of P5 Position in Substrates

Overview

Journal Apoptosis

Publisher Springer

Date 2008 Sep 10

PMID 18780184

Citations 17

Authors

Guoxing Fu

Alexander A Chumanevich

Johnson Agniswamy

Bin Fang

Robert W Harrison

Irene T Weber

Affiliations

Soon will be listed here.

Abstract

Caspase-3, -6 and -7 cleave many proteins at specific sites to induce apoptosis. Their recognition of the P5 position in substrates has been investigated by kinetics, modeling and crystallography. Caspase-3 and -6 recognize P5 in pentapeptides as shown by enzyme activity data and interactions observed in the crystal structure of caspase-3/LDESD and in a model for caspase-6. In caspase-3 the P5 main-chain was anchored by interactions with Ser209 in loop-3 and the P5 Leu side-chain interacted with Phe250 and Phe252 in loop-4 consistent with 50% increased hydrolysis of LDEVD relative to DEVD. Caspase-6 formed similar interactions and showed a preference for polar P5 in QDEVD likely due to interactions with polar Lys265 and hydrophobic Phe263 in loop-4. Caspase-7 exhibited no preference for P5 residue in agreement with the absence of P5 interactions in the caspase-7/LDESD crystal structure. Initiator caspase-8, with Pro in the P5-anchoring position and no loop-4, had only 20% activity on tested pentapeptides relative to DEVD. Therefore, caspases-3 and -6 bind P5 using critical loop-3 anchoring Ser/Thr and loop-4 side-chain interactions, while caspase-7 and -8 lack P5-binding residues.

Citing Articles

Selective chemical reagents to investigate the role of caspase 6 in apoptosis in acute leukemia T cells.

Groborz K, Kalinka M, Grzymska J, Kolt S, Snipas S, Poreba M Chem Sci. 2023; 14(9):2289-2302.

PMID: 36873853 PMC: 9977399. DOI: 10.1039/d2sc05827h.

Conformational transitions of caspase-6 in substrate-induced activation process explored by perturbation-response scanning combined with targeted molecular dynamics.

Huang S, Mei H, Lu L, Kuang Z, Heng Y, Xu L Comput Struct Biotechnol J. 2021; 19:4156-4164.

PMID: 34527189 PMC: 8342898. DOI: 10.1016/j.csbj.2021.07.017.

Design of a Human Rhinovirus-14 3C Protease-Inducible Caspase-3.

Wagner H, Weber W Molecules. 2019; 24(10).

PMID: 31117169 PMC: 6571611. DOI: 10.3390/molecules24101945.

A closed conformation of the Caenorhabditis elegans separase-securin complex.

Bachmann G, Richards M, Winter A, Beuron F, Morris E, Bayliss R Open Biol. 2016; 6(4):160032.

PMID: 27249343 PMC: 4852461. DOI: 10.1098/rsob.160032.

Small Molecule Active Site Directed Tools for Studying Human Caspases.

Poreba M, Szalek A, Kasperkiewicz P, Rut W, Salvesen G, Drag M Chem Rev. 2015; 115(22):12546-629.

PMID: 26551511 PMC: 5610424. DOI: 10.1021/acs.chemrev.5b00434.

References

Harrison R, Chatterjee D, Weber I . Analysis of six protein structures predicted by comparative modeling techniques. Proteins. 1995; 23(4):463-71. DOI: 10.1002/prot.340230402. View

Kim H, Lee J, Soung Y, Park W, Kim S, Lee J . Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology. 2003; 125(3):708-15. DOI: 10.1016/s0016-5085(03)01059-x. View

Hartmann A, Troadec J, Hunot S, Kikly K, Faucheux B, Mouatt-Prigent A . Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci. 2001; 21(7):2247-55. PMC: 6762382. View

Volkmann X, Cornberg M, Wedemeyer H, Lehner F, Manns M, Schulze-Osthoff K . Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection. Hepatology. 2006; 43(6):1311-6. DOI: 10.1002/hep.21186. View

Schweizer A, Briand C, Grutter M . Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway. J Biol Chem. 2003; 278(43):42441-7. DOI: 10.1074/jbc.M304895200. View

Lovell S, Davis I, Arendall 3rd W, de Bakker P, Word J, Prisant M . Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins. 2003; 50(3):437-50. DOI: 10.1002/prot.10286. View

Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View

Thornberry N, Rano T, Peterson E, Rasper D, Timkey T, Garcia-Calvo M . A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 1997; 272(29):17907-11. DOI: 10.1074/jbc.272.29.17907. View

Sheldrick G, Schneider T . SHELXL: high-resolution refinement. Methods Enzymol. 1997; 277:319-43. View

10.

Potterton E, Briggs P, Turkenburg M, Dodson E . A graphical user interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr. 2003; 59(Pt 7):1131-7. DOI: 10.1107/s0907444903008126. View

11.

Wei Y, Fox T, Chambers S, Sintchak J, Coll J, Golec J . The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem Biol. 2000; 7(6):423-32. DOI: 10.1016/s1074-5521(00)00123-x. View

12.

Fang B, Boross P, Tozser J, Weber I . Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition. J Mol Biol. 2006; 360(3):654-66. DOI: 10.1016/j.jmb.2006.05.041. View

13.

Emsley P, Cowtan K . Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 12 Pt 1):2126-32. DOI: 10.1107/S0907444904019158. View

14.

Wilson K, Black J, Thomson J, Kim E, Griffith J, Navia M . Structure and mechanism of interleukin-1 beta converting enzyme. Nature. 1994; 370(6487):270-5. DOI: 10.1038/370270a0. View

15.

Merritt E, Murphy M . Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 6):869-73. DOI: 10.1107/S0907444994006396. View

16.

Fischer U, Janicke R, Schulze-Osthoff K . Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003; 10(1):76-100. PMC: 7091709. DOI: 10.1038/sj.cdd.4401160. View

17.

Zidar N, Jera J, Maja J, Dusan S . Caspases in myocardial infarction. Adv Clin Chem. 2007; 44:1-33. DOI: 10.1016/s0065-2423(07)44001-x. View

18.

Baskin-Bey E, Washburn K, Feng S, Oltersdorf T, Shapiro D, Huyghe M . Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury. Am J Transplant. 2007; 7(1):218-25. DOI: 10.1111/j.1600-6143.2006.01595.x. View

19.

McCoy A, Grosse-Kunstleve R, Storoni L, Read R . Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr. 2005; 61(Pt 4):458-64. DOI: 10.1107/S0907444905001617. View

20.

Garcia-Calvo M, Peterson E, Rasper D, Vaillancourt J, Zamboni R, Nicholson D . Purification and catalytic properties of human caspase family members. Cell Death Differ. 1999; 6(4):362-9. DOI: 10.1038/sj.cdd.4400497. View